Tracking County-Level Measles Cases in the U.S. | Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | Adverse Events Associated with COVID-19 Vaccination or Diagnosis among Pregnant and Non-pregnant Women in the United States, 2021-2022
September 18, 2025 Read More »
Risk Factors for Severe Outcomes of Respiratory Syncytial Virus Infection in Children: A Nationwide Cohort Study in Sweden | Spillover of SARS-CoV-2 to Domestic Dogs in COVID-19–Positive Households: A One Health Surveillance Study
September 13, 2025 Read More »
This popular podcast produced by MicrobeTV and featuring Dr. Daniel Griffin (MD, Ph.D. CTropMed CTH) and Dr. Sara Dong (Ph.D.), aims to be a trusted and accessible tool to help busy clinicians, researchers, students and citizen scientists keep up-to-date on the latest infectious disease literature.
Increasing Access for Infectious Disease Puscast Read More »
Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine A Prespecified Secondary Analysis of the Randomized DANFLU-2 Trial |
Three Pharmaceutical Companies Announce U.S. FDA Approval for Updated COVID. The U.S. FDA’s Center for Biologics Evaluation and Research has suspended the biologics license for Valneva Austria GmbH’s live – attenuated IXCHIQ vaccine.
Ivermectin to Control Malaria — A Cluster-Randomized Trial | Relative Effectiveness of High-dose versus Standard-dose Influenza Vaccine against Hospitalizations and Mortality According to Frailty Score: A Post-hoc Analysis of the DANFLU-1 Randomized Trial
Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated with Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years |
Influenza With and Without Oseltamivir Treatment and Neuropsychiatric Events Among Children and Adolescents | Effectiveness of the BNT162b2 and mRNA-1273 JN.1-adapted Vaccines against COVID-19-associated Hospitalisation and Death: A Danish, Nationwide, Register-based, Cohort Study | Hospitalization for COVID-19 and Risk Factors for Severe Disease Among Children: 2022–2024
From August through to the end of October, Parasites Without Borders (PWB) will be matched by the organization and donated to the American Society of Tropical Medicine and Hygiene (ASTMH).
Fundraiser Kickoff for the American Society of Tropical Medicine and Hygiene Read More »
Effects of Baloxavir Marboxil Plus Neuraminidase Inhibitor versus Neuraminidase Inhibitor in High-risk Patients Hospitalized with Severe Influenza: A Post Hoc Analysis of the Flagstone Trial | Safety of JN.1-Updated mRNA COVID-19 Vaccines | Prevalence of Persistent Cardiovascular and Pulmonary Abnormalities on PET/MRI and DECT Imaging in Long COVID Patients
A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.
Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.
English 
Spanish